Atrial Fibrillation
AF detection, rhythm-monitoring access, diagnostic yield, and therapy-handoff visuals.
Projected prevalence, age-linked risk, hospitalizations, silent disease, and anticoagulation handoffs frame AFib as a population-scale rhythm-management problem.
How monitoring duration, workflow follow-through, and access change whether intermittent AF becomes an actionable signal.
Why AF pathways depend on detection yield, stroke risk, symptom burden, anticoagulation decisions, rhythm strategy, and clean handoff to longitudinal care.
Monitoring yield, anticoagulation decisions, rhythm care, stroke prevention, and specialist access shape the AF market.
Detection access, monitoring yield, stroke prevention, rhythm-care capacity, and longitudinal adherence reinforce the AF care market.
AF care shifts from incidental detection and remote monitoring to primary care, cardiology, electrophysiology, and longitudinal anticoagulation support.